期刊文献+

替米沙坦对大鼠冠状动脉微栓形成后心肌细胞凋亡的影响 被引量:2

Influnence of Telmisartan on the Apoptosis of Rat Cardiomyocyte in Coronary Microthrombosis
下载PDF
导出
摘要 目的:建立冠脉微血栓模型,观察冠脉微血栓后心肌细胞的凋亡和对心功能的影响,并观察替米沙坦对微血栓形成和心肌细胞凋亡的影响。方法:将SPF级SD大鼠冠状动脉注射月桂酸钠400μg后,随机分入微栓组和替米沙坦组(饮水中给药10mg·kg-1·d-1),对照组则以等量生理盐水替代月桂酸钠。术前和术后28d行超声心动图检查,术后行心肌TUNEL染色检测凋亡心肌细胞数。结果:在急性实验中与对照组相比微栓组和替米沙坦组冠脉内微血栓形成率、TnI值、心肌细胞凋亡率均显著增加(P<0.01),而微栓组与替米沙坦组之间差异无统计学意义(P>0.05)。在慢性实验中替米沙坦组较微栓组左室舒张末期内径(LVEDD)减小(P<0.01),左室射血分数(LVEF)增加(P<0.01);替米沙坦组心肌细胞凋亡率显著低于微栓组(P<0.01)。慢性实验中,冠状动脉微栓塞形成28d后,心肌细胞凋亡率与大鼠LVEDD和LVEF之间均呈明显正相关(均P<0.01)。结论:冠状动脉内注射月桂酸钠能够成功建立冠状动脉微血栓的模型;冠脉内微血栓增加心肌细胞的凋亡,是导致心功能下降的原因之一;替米沙坦能有效地抑制心脏重塑,改善心功能,并能抑制冠脉微血栓后心肌细胞的凋亡。 Objective: To establish a new type of coronary microthromboembolism model. To observe cardiomyocytes apoptosis and the changes of heart function,and to observe the effect of ARB on microthrombogenesis and apoptosis. Methods: In acute or chronic experiment,all SD rats were randomly divided into three groups which included microthromboembolism group with the injection of 400 μg sodium laurate into the coronary arteries of SD rats, TS group with drinking telmisartan (10 mg/kg),and NS group with NS instead of sodium laurate. UCG was applied before and 28 d postoperatively. Cardiomyocyte apoptosis was detected by TUNEL staining. Results: cTnI concentration in blood, apoptosis rate of myocardial cells and the rate of microthromboembolism in microthromboembolism group and TS group were significantly higher than that in control group in acute experiment (P 〈 0.01 ),and there was no significant difference between rnicrothromboembolism group and TS group (P 〉 0.05 ). LVEDD in microthromboembolism group and TS group decreased compared to that in control group in chronic experiment (P 〈 0.01 ),and LVEF increased than that in control group (P 〈 0.01 ). Apoptosis rate of myocardial cells in TS group was lower than that in microthromboembolism group (P〈 0.01 ). There was a positive correlation between Apoptosis rate of myocardial cells and LVEDD and LVEF 28 days after ism in chronic experiment (P 〈 0.01 ). Conclusion: A coronary microthromboembolism model was successfully established by injecting sodium laurate into the coronary arteries. Coronary micro-thrombogenesis may promote the apoptosis of cardiomyocytes,and is one of the reason for heart function decrease. Telmisartan can efficiently suppress ventricles reconstruction, improve heart function, and inhibit the apoptosis of myocardial cells after microthrombogenesis in coronary artery.
出处 《天津医药》 CAS 北大核心 2008年第6期454-456,I0004,共4页 Tianjin Medical Journal
基金 天津市卫生局科技研究课题(项目编号:04KZ41)
关键词 血管紧张素Ⅱ1型受体拮抗剂 冠状血管 血栓形成 心肌 细胞凋亡 模型 动物 大鼠 angiotensin Ⅱ type 1 receptor blockers coronary vessels thrombosis myocardium apoptosismodels, animal rats
  • 相关文献

参考文献6

  • 1丛洪良,张梅,王伟,陈树涛,徐延敏,周长钰,李广平,黄体钢.急性冠状动脉综合征患者经皮冠状动脉介入术后无复流现象的危险因素及预后[J].中国介入心脏病学杂志,2006,14(1):34-36. 被引量:6
  • 2Schmermund A,Lerman LO,Rumberger JA,et al. Effects of acute and chronic angiotension receptor blockade on myocardial vascular volume and perfusion in a pig model of coronary microembolization [J]. Am J Hypertens ,2000,13(7) :827-837.
  • 3Toshima Y,Satoh S,Ikegaki I,et al. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor[J]. Stroke, 2000,31 (9) : 2245-2250.
  • 4Saavedra WF,Tunin RS, Paolocci N, et al. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure [J]. J Am Coll Cardiol, 2002,39 (12): 2069-2076.
  • 5Cigola E,Kajstura J,Li B,et al. Angiotensin Ⅱ activates programmed myocyte cell death in vitro [J]. Exp Cell Res, 1997,231 (2) :363-371.
  • 6Kitsis RN,Nam YJ,Mani K,et al. Inhibition of both the extrinsic and intrinsic death pathways through non-homotypic death-fold interactions[J]. Mol Cell, 2004,15 : 901-912.

二级参考文献6

  • 1Gin S,Mitchel J F,Hirst JA,et al.Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction.Am J Cardial,2000,86:269-274.
  • 2Wainstein M,Frederic F,Lee M,et al.Lack of clinical efficacy of pharmacologic treatment of the no-reflow phenomenon despite significant angiographic improvement.J Am Coll Cardiol,2001,37:83-86.
  • 3Iwakura K,Ito H,Ikushima M,et al.Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.J Am Coll Cardiol,2003,41:1-7.
  • 4Kojima S,Sakamoto T,Ishihara M.The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era.Ann Med,2004,36:153-160.
  • 5Morishima I,Sone T,Okumura K,et al.Aniographic no-reflow phenomenon as a predictor of adverse long term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.J Am Coll Cardiol,2000,36:1202-1209.
  • 6Resnic FS,Wainstein M,Lee MK,et al.No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.Am Heart J,2003,145:9-11.

共引文献5

同被引文献25

  • 1李侠,董士民,刘坤申.螺内酯、氯沙坦对AMI大鼠血浆胶原代谢产物及心肌组织心钠素、醛固酮的影响[J].山东医药,2007,47(4):21-22. 被引量:1
  • 2吴强,杨永曜,李隆贵,杨天和,蔡运昌,蒋清安.非诺贝特和吡格列酮对血管紧张素Ⅱ介导的心肌细胞肥大和凋亡的干预作用[J].中华高血压杂志,2007,15(3):233-237. 被引量:7
  • 3Goldstein JA, Maini B, Dixon SR, et al. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction [ J ]. Circ Cardiovasc In- terv, 2011,4 ( 5 ) :429-437.
  • 4Testa L, Van Gaal WJ, Biondi Zoecai GG, et al. Myocardial in- farction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition [ J ]. QJM, 2009,102(6) :369-378.
  • 5Tibolla G, Norata GD, Meda C, et al. Increased atheroselerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency[ J]. Atherosclerosis, 2010,210( 1 ) :78-87.
  • 6Gurbel PA, Bliden KP, Sancedo JF, et al. Bivalirudin and clopi- dogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 ( Clo- pidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study [J]. J Am Coil Cardiol, 2009,24(53) :648-657.
  • 7Vilahur G, Juan-Babot O, Pena E, et al. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction [ J ]. J Mol Cell Cardiol, 2011,50 ( 3 ) :522-533.
  • 8Nienhuis MB, Ottervanger JP, Bilo HJ, et al. Prognostic value of troponin after elective percutaneous coronary intervention: A meta- analvsis[J]. Catheter Cardiovasc Interv, 2008,71 (3) :318-324.
  • 9Jugdutt BI, Jelani A, Palaniyappan A, et al. Aging-related early changes in markers of ventricular and matrix remodeling after reper- fused ST-segment elevation myocardial infarction in the canine mod- el: effect of early therapy with an angiotensin II type 1 receptor blocker[J]. Circulation, 2010,122(4) :341-351.
  • 10Mega S, Nusca A, Patti G. Percutaneous coronary interventions and statin therapy [ J ]. Recenti Prog Med, 2012,103 ( 1 ) : 5-10.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部